Capsaicin induces cytotoxicity in human osteosarcoma MG63 cells through TRPV1-dependent and -independent pathways

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Capsaicin demonstrates anti-tumor properties by inducing apoptosis in various cancer cells.
• The specific mechanisms of capsaicin's effects on osteosarcoma remain incompletely understood.
• Osteosarcoma is a primary bone cancer with significant unmet therapeutic needs.

Purpose of the Study:

• To investigate the molecular mechanisms underlying capsaicin's tumor-suppressive effects in osteosarcoma.
• To explore the roles of transient receptor potential receptor vanilloid 1 (TRPV1) and other signaling pathways in capsaicin-induced apoptosis.
• To evaluate capsaicin as a potential therapeutic agent for osteosarcoma.

Main Methods:

• In vitro study using human osteosarcoma MG63 cells.
• Assessed capsaicin's effects on cell viability, apoptosis, and mitochondrial function.
• Utilized TRPV1 antagonist (capsazepine) and AMPK antagonist (Compound C) to elucidate signaling pathways.
• Measured reactive oxygen species (ROS) production and superoxide dismutase (SOD) activity.

Main Results:

• Capsaicin induced apoptosis and activated TRPV1 in a dose- and time-dependent manner.
• Blocking TRPV1 attenuated capsaicin-induced cytotoxicity, mitochondrial dysfunction, ROS overproduction, and reduced SOD activity.
• Capsaicin activated adenosine 5'-monophosphate-activated protein kinase (AMPK), p53, and C-jun N-terminal kinase (JNK).
• Compound C inhibited p53 activation, indicating a TRPV1-independent pathway involving AMPK.

Conclusions:

• Capsaicin induces cell death in human osteosarcoma cells through both TRPV1-dependent (mitochondrial dysfunction, ROS, JNK) and TRPV1-independent (AMPK-p53) pathways.
• The findings suggest that capsaicin possesses significant anti-osteosarcoma potential.
• Capsaicin warrants further investigation as a novel therapeutic agent for osteosarcoma treatment.